NYSE:ZTS - Zoetis Stock Price, Price Target & More

$85.41 -0.43 (-0.50 %)
(As of 04/19/2018 03:06 PM ET)
Previous Close$85.97
Today's Range$84.82 - $85.89
52-Week Range$53.65 - $86.38
Volume1.53 million shs
Average Volume2.72 million shs
Market Capitalization$41.57 billion
P/E Ratio35.43
Dividend Yield0.59%
Beta0.96

About Zoetis (NYSE:ZTS)

Zoetis logoZoetis Inc. discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. In addition, the company offers other product categories, including nutritionals and agribusiness services, as well as products and services in complementary areas, such as biodevices, diagnostics, and genetics. It markets its products to veterinarians, livestock producers, and people who raise and care for farm and companion animals through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Receive ZTS News and Ratings via Email

Sign-up to receive the latest news and ratings for ZTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNYSE:ZTS
CUSIP98978V10
Phone973-822-7000

Debt

Debt-to-Equity Ratio2.77%
Current Ratio3.85%
Quick Ratio2.55%

Price-To-Earnings

Trailing P/E Ratio35.43
Forward P/E Ratio28.10
P/E Growth1.9

Sales & Book Value

Annual Sales$5.31 billion
Price / Sales7.81
Cash Flow$2.92 per share
Price / Cash29.25
Book Value$3.67 per share
Price / Book23.27

Profitability

EPS (Most Recent Fiscal Year)$2.40
Net Income$864 million
Net Margins16.28%
Return on Equity65.96%
Return on Assets14.22%

Miscellaneous

Employees9,200
Outstanding Shares485,250,000

How to Become a New Pot Stock Millionaire

Zoetis (NYSE:ZTS) Frequently Asked Questions

What is Zoetis' stock symbol?

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

How often does Zoetis pay dividends? What is the dividend yield for Zoetis?

Zoetis declared a quarterly dividend on Wednesday, February 14th. Stockholders of record on Friday, April 20th will be paid a dividend of $0.126 per share on Friday, June 1st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date is Thursday, April 19th. View Zoetis' Dividend History.

How were Zoetis' earnings last quarter?

Zoetis (NYSE:ZTS) announced its quarterly earnings results on Thursday, February, 15th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.66 by $0.03. The firm earned $1.46 billion during the quarter, compared to the consensus estimate of $1.40 billion. Zoetis had a net margin of 16.28% and a return on equity of 65.96%. The business's quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.47 earnings per share. View Zoetis' Earnings History.

When is Zoetis' next earnings date?

Zoetis is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Zoetis.

What guidance has Zoetis issued on next quarter's earnings?

Zoetis issued an update on its FY18 earnings guidance on Thursday, February, 15th. The company provided EPS guidance of $2.96-3.10 for the period, compared to the Thomson Reuters consensus estimate of $2.98. The company issued revenue guidance of $5.675-5.8 billion, compared to the consensus revenue estimate of $5.62 billion.

What price target have analysts set for ZTS?

18 Wall Street analysts have issued 1 year price objectives for Zoetis' stock. Their forecasts range from $62.00 to $98.00. On average, they expect Zoetis' stock price to reach $81.5294 in the next year. View Analyst Ratings for Zoetis.

What are Wall Street analysts saying about Zoetis stock?

Here are some recent quotes from research analysts about Zoetis stock:
  • 1. According to Zacks Investment Research, "Zoetis faces stiff competition from other animal health medicines and vaccines companies like Merck Animal Health (the animal health division of Merck), Elanco (the animal health division of Eli Lilly), Bayer Animal Health (the animal health division of Bayer) and Boehringer Ingelheim Animal Health (the animal health division of Boehringer Ingelheim). Disease outbreak among animals is a material cause of concern for Zoetis’ livestock products.In addition, companion animal health products are often directly prescribed and dispensed by veterinarians. The swine business is being impacted by competition for Fostera. These competitive pressures could adversely affect the company’s business and operating results. However, shares of the company have outperformed the industry in the last six months." (1/13/2018)
  • 2. Cantor Fitzgerald analysts commented, "IDEXX Laboratories this morning provided strong 2018 organic growth forecasts of 9% to 11% driven by the strong growth in its Companion Animal Diagnostics segment." (10/31/2017)

Who are some of Zoetis' key competitors?

Who are Zoetis' key executives?

Zoetis' management team includes the folowing people:
  • Mr. Juan Ramón Alaix, CEO & Director (Age 67)
  • Mr. Glenn C. David, Exec. VP, CFO & Principal Accounting Officer (Age 46)
  • Mr. Clinton A. Lewis Jr., Exec. VP & Pres of International Operations (Age 51)
  • Dr. Catherine A. Knupp, Exec. VP and Pres of R&D (Age 57)
  • Ms. Kristin C. Peck, Exec. VP and Group Pres, U.S. Operations, Bus. Devel. & Strategy (Age 47)

Has Zoetis been receiving favorable news coverage?

News headlines about ZTS stock have been trending somewhat negative recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Zoetis earned a media sentiment score of -0.03 on Accern's scale. They also assigned press coverage about the company an impact score of 47.01 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Zoetis?

Shares of ZTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zoetis' stock price today?

One share of ZTS stock can currently be purchased for approximately $85.41.

How big of a company is Zoetis?

Zoetis has a market capitalization of $41.57 billion and generates $5.31 billion in revenue each year. The company earns $864 million in net income (profit) each year or $2.40 on an earnings per share basis. Zoetis employs 9,200 workers across the globe.

How can I contact Zoetis?

Zoetis' mailing address is 10 Sylvan Way, Parsippany NJ, 07054. The company can be reached via phone at 973-822-7000 or via email at [email protected]


MarketBeat Community Rating for Zoetis (ZTS)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  513 (Vote Outperform)
Underperform Votes:  305 (Vote Underperform)
Total Votes:  818
MarketBeat's community ratings are surveys of what our community members think about Zoetis and other stocks. Vote "Outperform" if you believe ZTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZTS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Zoetis (NYSE:ZTS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
18 Wall Street analysts have issued ratings and price targets for Zoetis in the last 12 months. Their average twelve-month price target is $81.5294, suggesting that the stock has a possible downside of 4.54%. The high price target for ZTS is $98.00 and the low price target for ZTS is $62.00. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.612.672.672.63
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $81.5294$79.5294$73.1765$65.4375
Price Target Upside: 4.54% downside5.99% downside4.68% downside3.33% upside

Zoetis (NYSE:ZTS) Consensus Price Target History

Price Target History for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/19/2018Hilliard LyonsDowngradeNeutralLowView Rating Details
4/19/2018CitigroupReiterated RatingBuy$85.00 -> $98.00MediumView Rating Details
4/13/2018Jefferies GroupReiterated RatingBuy$96.00LowView Rating Details
4/5/2018Credit Suisse GroupBoost Price TargetOutperform -> Outperform$83.00 -> $89.00LowView Rating Details
3/19/2018Morgan StanleyDowngradeOverweight -> Equal Weight$70.00LowView Rating Details
2/17/2018BarclaysSet Price TargetHold$77.00MediumView Rating Details
2/16/2018Deutsche BankBoost Price TargetHold -> Hold$76.00 -> $78.00LowView Rating Details
2/16/2018Piper JaffraySet Price TargetBuy$88.00LowView Rating Details
2/16/2018Stifel NicolausReiterated RatingBuy -> Buy$84.00 -> $86.00MediumView Rating Details
2/16/2018Bank of AmericaBoost Price TargetBuy$80.00 -> $87.00MediumView Rating Details
2/15/2018Cantor FitzgeraldSet Price TargetBuy$90.00MediumView Rating Details
2/15/2018BMO Capital MarketsSet Price TargetHold$78.00MediumView Rating Details
2/15/2018CowenSet Price TargetBuy$85.00MediumView Rating Details
1/2/2018Craig HallumReiterated RatingBuy$77.00 -> $85.00LowView Rating Details
11/24/2017UBSReiterated RatingBuy -> NeutralN/AView Rating Details
8/7/2017Goldman SachsReiterated RatingNeutral -> Neutral$62.00LowView Rating Details
5/30/2017ArgusReiterated RatingBuy$60.00 -> $69.00LowView Rating Details
5/26/2017CL KingInitiated CoverageBuy -> Buy$71.00LowView Rating Details
2/16/2017GuggenheimBoost Price TargetBuy$60.00 -> $65.00N/AView Rating Details
2/16/2017Off Wall StreetReiterated RatingStrong Sell$35.00N/AView Rating Details
11/3/2016JPMorgan ChaseReiterated RatingHold$53.00N/AView Rating Details
(Data available from 4/19/2016 forward)

Earnings

Zoetis (NYSE:ZTS) Earnings History and Estimates Chart

Earnings by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Earnings Estimates

2018 EPS Consensus Estimate: $3.05
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.70$0.71$0.71
Q2 20181$0.72$0.72$0.72
Q3 20181$0.79$0.79$0.79
Q4 20181$0.83$0.83$0.83

Zoetis (NYSE ZTS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.68N/AView Earnings Details
2/15/2018Q4 2017$0.66$0.69$1.4034 billion$1.46 billionViewN/AView Earnings Details
11/2/2017Q3 2017$0.63$0.65$1.3206 billion$1.3470 billionViewN/AView Earnings Details
8/8/2017Q2 2017$0.53$0.5280$1.2660 billion$1.2690 billionViewListenView Earnings Details
5/4/2017Q1 2017$0.48$0.53$1.1967 billion$1.2310 billionViewListenView Earnings Details
2/16/2017Q416$0.45$0.47$1.28 billion$1.30 billionViewN/AView Earnings Details
11/2/2016Q316$0.46$0.52$1.22 billion$1.20 billionViewN/AView Earnings Details
8/3/2016Q216$0.44$0.49$1.17 billion$1.20 billionViewN/AView Earnings Details
5/4/2016Q116$0.41$0.48$1.10 billion$1.20 billionViewN/AView Earnings Details
2/16/2016Q415$0.39$0.43$1.25 billion$1.30 billionViewListenView Earnings Details
11/3/2015Q315$0.40$0.50$1.18 billion$1.20 billionViewN/AView Earnings Details
8/4/2015Q215$0.38$0.43$1.12 billion$1.20 billionViewN/AView Earnings Details
5/5/2015Q115$0.37$0.41$1.11 billion$1.10 billionViewN/AView Earnings Details
2/11/2015Q414$0.36$0.40$1.27 billion$1.30 billionViewN/AView Earnings Details
11/4/2014Q314$0.37$0.41$1.16 billion$1.20 billionViewN/AView Earnings Details
8/5/2014Q2 2014$0.39$0.38$1.1640 billion$1.1580 billionViewN/AView Earnings Details
5/6/2014Q114$0.37$0.38$1.13 billion$1.10 billionViewN/AView Earnings Details
2/11/2014Q413$0.34$0.36$1.21 billion$1.25 billionViewN/AView Earnings Details
11/5/2013Q313$0.34$0.34$1.07 billion$1.10 billionViewN/AView Earnings Details
8/6/2013Q2 2013$0.36$0.36$1.13 billion$1.1140 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.27$0.36$1.24 billion$1.09 billionViewN/AView Earnings Details
3/28/2013Q4 2012$0.34$0.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Zoetis (NYSE:ZTS) Dividend Information

Zoetis pays an annual dividend of $0.50 per share, with a dividend yield of 0.59%. ZTS's next quarterly dividend payment will be made on Friday, June 1. The company has grown its dividend for the last 4 consecutive years and is increasing its dividend by an average of 13.40% each year. Zoetis pays out 20.83% of its earnings out as a dividend.
Next Dividend:6/1/2018
Annual Dividend:$0.50
Dividend Yield:0.59%
Dividend Growth:13.40% (3 Year Average)
Payout Ratio:20.83% (Trailing 12 Months of Earnings)
16.45% (Based on This Year's Estimates)
14.58% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2018quarterly$0.12600.68%4/19/20184/20/20186/1/2018
12/12/2017quarterly$0.12600.7%1/18/20181/19/20183/1/2018
10/5/2017quarterly$0.10500.66%11/8/201711/9/201712/1/2017
5/12/2017quarterly$0.10500.7%6/13/20176/15/20179/1/2017
2/15/2017quarterly$0.10500.76%4/4/20174/6/20176/1/2017
12/6/2016quarterly$0.10500.82%1/18/20171/20/20173/1/2017
10/7/2016quarterly$0.09500.73%11/1/201611/3/201612/1/2016
5/13/2016quarterly$0.09500.82%6/28/20166/30/20168/30/2016
2/22/2016quarterly$0.09500.89%4/5/20164/7/20166/1/2016
12/17/2015quarterly$0.09500.81%1/19/20161/21/20163/1/2016
10/2/2015quarterly$0.08300.77%11/3/201511/5/201512/1/2015
7/22/2015quarterly$0.08300.66%8/11/20158/13/20159/1/2015
3/2/2015quarterly$0.08300.7%4/7/20154/9/20156/2/2015
12/18/2014quarterly$0.08300.77%1/20/20151/22/20153/3/2015
10/2/2014quarterly$0.07200.76%11/3/201411/5/201412/2/2014
7/31/2014quarterly$0.07200.88%8/18/20148/20/20149/2/2014
3/26/2014quarterly$0.07200.98%4/23/20144/27/20146/2/2014
12/19/2013quarterly$0.07200.89%1/28/20141/30/20143/4/2014
9/12/2013quarterly$0.06500.84%10/30/201311/1/201312/2/2013
6/20/2013quarterly$0.06508/1/20139/2/2013
3/29/2013special$0.06504/29/20135/1/20136/6/2013
3/28/2013quarterly$0.06505/1/20136/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

Zoetis (NYSE ZTS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.35%
Institutional Ownership Percentage: 92.33%
Insider Trading History for Zoetis (NYSE:ZTS)
Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE ZTS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2018Heidi C ChenInsiderSell7,383$84.71$625,413.9320,162View SEC Filing  
3/9/2018Roman TrawickiInsiderSell8,568$83.10$712,000.8011,457View SEC Filing  
2/23/2018Roman TrawickiInsiderSell23,885$82.00$1,958,570.00View SEC Filing  
2/21/2018Roxanne LaganoEVPSell35,663$81.02$2,889,416.2649,919View SEC Filing  
2/20/2018Heidi C ChenInsiderSell37,453$81.02$3,034,442.06View SEC Filing  
5/12/2017Catherine A KnuppInsiderSell5,785$60.16$348,025.6024,415View SEC Filing  
11/22/2016Kristin C PeckInsiderSell10,092$49.55$500,058.6022,768View SEC Filing  
11/8/2016Roxanne LaganoInsiderSell9,797$50.43$494,062.718,063View SEC Filing  
9/6/2016Michael B MccallisterDirectorBuy2,000$51.34$102,680.00View SEC Filing  
9/2/2016Andrew FentonInsiderSell13,870$51.25$710,837.5017,719View SEC Filing  
9/1/2016Heidi C ChenInsiderSell32,097$50.98$1,636,305.0646,060View SEC Filing  
5/9/2016Pershing Square Capital ManageDirectorSell16,850,000$46.55$784,367,500.00View SEC Filing  
8/8/2013Michael MccallisterDirectorBuy7,000$31.35$219,450.00View SEC Filing  
2/6/2013Frank A DamelioDirectorBuy5,000$26.00$130,000.00View SEC Filing  
2/6/2013Sandra J BeatyEVPBuy2,000$26.00$52,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Zoetis (NYSE ZTS) News Headlines

Source:
DateHeadline
Zoetis (ZTS) Downgraded by Hilliard Lyons to "Neutral"Zoetis (ZTS) Downgraded by Hilliard Lyons to "Neutral"
www.americanbankingnews.com - April 19 at 10:42 AM
UPDATE: Zoetis Inc. (ZTS) PT Raised to Street High $98 at CitiUPDATE: Zoetis Inc. (ZTS) PT Raised to Street High $98 at Citi
www.streetinsider.com - April 19 at 9:57 AM
Zoetis (ZTS) Earns "Buy" Rating from CitigroupZoetis (ZTS) Earns "Buy" Rating from Citigroup
www.americanbankingnews.com - April 19 at 9:04 AM
Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 19, 2018Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 19, 2018
www.nasdaq.com - April 18 at 10:00 AM
Zoetis (ZTS) Given a $70.00 Price Target at CowenZoetis (ZTS) Given a $70.00 Price Target at Cowen
www.americanbankingnews.com - April 17 at 10:55 PM
Ex-Dividend Reminder: Foot Locker, Zoetis and First BuseyEx-Dividend Reminder: Foot Locker, Zoetis and First Busey
www.nasdaq.com - April 17 at 4:25 PM
Jefferies Group Comments on Zoetis Q1 2018 Earnings (ZTS)Jefferies Group Comments on Zoetis' Q1 2018 Earnings (ZTS)
www.americanbankingnews.com - April 16 at 1:12 AM
Jefferies Group Analysts Give Zoetis (ZTS) a $96.00 Price TargetJefferies Group Analysts Give Zoetis (ZTS) a $96.00 Price Target
www.americanbankingnews.com - April 13 at 10:13 AM
Goldman Sachs Reaffirms "Neutral" Rating for Zoetis (ZTS)Goldman Sachs Reaffirms "Neutral" Rating for Zoetis (ZTS)
www.americanbankingnews.com - April 12 at 11:52 PM
$1.33 Billion in Sales Expected for Zoetis Inc (ZTS) This Quarter$1.33 Billion in Sales Expected for Zoetis Inc (ZTS) This Quarter
www.americanbankingnews.com - April 12 at 2:40 AM
Zoetis Stock Performance in 1Q18Zoetis Stock Performance in 1Q18
finance.yahoo.com - April 10 at 4:14 PM
 Brokerages Expect Zoetis Inc (ZTS) Will Post Earnings of $0.69 Per Share Brokerages Expect Zoetis Inc (ZTS) Will Post Earnings of $0.69 Per Share
www.americanbankingnews.com - April 10 at 3:18 PM
Trade-War Olive Branch Fuels Rise By Stocks In 'Best Mutual Funds'Trade-War Olive Branch Fuels Rise By Stocks In 'Best Mutual Funds'
finance.yahoo.com - April 10 at 10:03 AM
Zoetis (ZTS) Rating Reiterated by Stifel NicolausZoetis (ZTS) Rating Reiterated by Stifel Nicolaus
www.americanbankingnews.com - April 9 at 4:40 PM
Zoetis (ZTS) Upgraded to Strong-Buy by BidaskClubZoetis (ZTS) Upgraded to Strong-Buy by BidaskClub
www.americanbankingnews.com - April 9 at 12:24 AM
Zoetis (ZTS) Given Buy Rating at Stifel NicolausZoetis (ZTS) Given Buy Rating at Stifel Nicolaus
www.americanbankingnews.com - April 5 at 9:36 PM
Zoetis (ZTS) Rating Reiterated by Cantor FitzgeraldZoetis (ZTS) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - April 5 at 7:26 PM
May 25th Options Now Available For Zoetis (ZTS)May 25th Options Now Available For Zoetis (ZTS)
www.nasdaq.com - April 5 at 4:15 PM
Zoetis Inc (ZTS) Receives Consensus Recommendation of "Buy" from BrokeragesZoetis Inc (ZTS) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 5 at 3:36 PM
Zoetis (ZTS) Price Target Raised to $89.00Zoetis (ZTS) Price Target Raised to $89.00
www.americanbankingnews.com - April 5 at 12:56 PM
BMO Capital Markets Analysts Give Zoetis (ZTS) a $65.00 Price TargetBMO Capital Markets Analysts Give Zoetis (ZTS) a $65.00 Price Target
www.americanbankingnews.com - April 5 at 12:39 PM
BidaskClub Downgrades Zoetis (ZTS) to HoldBidaskClub Downgrades Zoetis (ZTS) to Hold
www.americanbankingnews.com - April 4 at 11:26 PM
Zoetis (ZTS) Upgraded by ValuEngine to "Buy"Zoetis (ZTS) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - April 2 at 10:26 PM
Zoetis (ZTS) Given a $75.00 Price Target at Cantor FitzgeraldZoetis (ZTS) Given a $75.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - April 2 at 8:40 PM
Zoetis (ZTS) Downgraded to Sell at BidaskClubZoetis (ZTS) Downgraded to Sell at BidaskClub
www.americanbankingnews.com - April 2 at 5:52 PM
Zoetis (ZTS) Receives "Buy" Rating from Craig HallumZoetis (ZTS) Receives "Buy" Rating from Craig Hallum
www.americanbankingnews.com - March 31 at 12:16 PM
Cantor Fitzgerald Analysts Give Zoetis (ZTS) a $85.00 Price TargetCantor Fitzgerald Analysts Give Zoetis (ZTS) a $85.00 Price Target
www.americanbankingnews.com - March 31 at 12:16 PM
Zoetis (ZTS) Upgraded by Citigroup to BuyZoetis (ZTS) Upgraded by Citigroup to Buy
www.americanbankingnews.com - March 30 at 5:08 PM
Buy Align Technology And Zoetis - Cramers Lightning Round (3/28/18)Buy Align Technology And Zoetis - Cramer's Lightning Round (3/28/18)
seekingalpha.com - March 29 at 10:12 AM
Zoetis to Host Webcast and Conference Call on First Quarter 2018 Financial ResultsZoetis to Host Webcast and Conference Call on First Quarter 2018 Financial Results
finance.yahoo.com - March 29 at 10:12 AM
Cantor Fitzgerald Reiterates $85.00 Price Target for Zoetis (ZTS)Cantor Fitzgerald Reiterates $85.00 Price Target for Zoetis (ZTS)
www.americanbankingnews.com - March 28 at 7:06 PM
The Leaders Stagger: Cramers Mad Money Recap (Tuesday 3/27/18)The Leaders Stagger: Cramer's 'Mad Money' Recap (Tuesday 3/27/18)
www.thestreet.com - March 28 at 9:48 AM
Zoetis Is Expanding Healthcare Products for Pets, LivestockZoetis Is Expanding Healthcare Products for Pets, Livestock
finance.yahoo.com - March 28 at 9:48 AM
Zoetis (ZTS) Given "Buy" Rating at Piper JaffrayZoetis (ZTS) Given "Buy" Rating at Piper Jaffray
www.americanbankingnews.com - March 27 at 12:34 PM
Zoetis Inc (ZTS) Expected to Post Quarterly Sales of $1.33 BillionZoetis Inc (ZTS) Expected to Post Quarterly Sales of $1.33 Billion
www.americanbankingnews.com - March 26 at 4:54 AM
Critical Comparison: Zoetis (ZTS) & Acer Therapeutics (ACER)Critical Comparison: Zoetis (ZTS) & Acer Therapeutics (ACER)
www.americanbankingnews.com - March 25 at 11:15 PM
 Brokerages Anticipate Zoetis Inc (ZTS) to Announce $0.69 Earnings Per Share Brokerages Anticipate Zoetis Inc (ZTS) to Announce $0.69 Earnings Per Share
www.americanbankingnews.com - March 24 at 5:20 PM
Critical Comparison: Zoetis (ZTS) & Cara Therapeutics (CARA)Critical Comparison: Zoetis (ZTS) & Cara Therapeutics (CARA)
www.americanbankingnews.com - March 21 at 11:10 PM
Morgan Stanley Downgrades Zoetis Inc. (ZTS) to Equalweight - StreetInsider.comMorgan Stanley Downgrades Zoetis Inc. (ZTS) to Equalweight - StreetInsider.com
www.streetinsider.com - March 20 at 4:22 PM
Zoetis Inc (ZTS) Insider Heidi C. Chen Sells 7,383 SharesZoetis Inc (ZTS) Insider Heidi C. Chen Sells 7,383 Shares
www.americanbankingnews.com - March 19 at 7:28 PM
Zoetis (ZTS) Rating Lowered to Equal Weight at Morgan StanleyZoetis (ZTS) Rating Lowered to Equal Weight at Morgan Stanley
www.americanbankingnews.com - March 19 at 6:12 PM
Zoetis Downgraded As Valuation Approaches Morgan Stanleys Price Target - BenzingaZoetis Downgraded As Valuation Approaches Morgan Stanley's Price Target - Benzinga
www.benzinga.com - March 19 at 4:21 PM
Zoetis Downgraded As Valuation Approaches Morgan Stanleys Price TargetZoetis Downgraded As Valuation Approaches Morgan Stanley's Price Target
finance.yahoo.com - March 19 at 4:21 PM
Morgan Stanley Downgrades Zoetis Inc. (ZTS) to EqualweightMorgan Stanley Downgrades Zoetis Inc. (ZTS) to Equalweight
www.streetinsider.com - March 19 at 10:30 AM
Reading Merck’s Animal Health in 2017: A Post-4Q17 UpdateReading Merck’s Animal Health in 2017: A Post-4Q17 Update
finance.yahoo.com - March 19 at 10:30 AM
Zoetis (ZTS) Up 7.8% Since Earnings Report: Can It Continue?Zoetis (ZTS) Up 7.8% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 19 at 10:30 AM
Roman Trawicki Sells 8,568 Shares of Zoetis Inc (ZTS) StockRoman Trawicki Sells 8,568 Shares of Zoetis Inc (ZTS) Stock
www.americanbankingnews.com - March 12 at 7:40 PM
Zoetis Inc (ZTS) Receives Consensus Recommendation of "Buy" from AnalystsZoetis Inc (ZTS) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 11 at 5:55 PM
Granite Investment Advisors LLC Purchases Shares of 14,209 Zoetis Inc (ZTS)Granite Investment Advisors LLC Purchases Shares of 14,209 Zoetis Inc (ZTS)
www.americanbankingnews.com - March 6 at 2:04 PM
Independent Franchise Partners LLP Sells 180,109 Shares of Zoetis Inc (ZTS)Independent Franchise Partners LLP Sells 180,109 Shares of Zoetis Inc (ZTS)
www.americanbankingnews.com - March 6 at 9:04 AM

SEC Filings

Zoetis (NYSE:ZTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Zoetis (NYSE:ZTS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Zoetis (NYSE ZTS) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.